News

Cathy Tie slips on a white lab coat bearing her name and the logo of her startup: Origin Genomics. "Welcome!" she says as she leads an NPR reporter, photographer and videographer on an exclusive tour of Origin's labs located...

This is the 17th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in...

THE INSTAGRAM POST, precision-guided by sex and age, had zeroed in on its target. Yuchen Tu is a conser­vatory-trained viola...

This is the 16th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...

By Erika Check Hayden, Nature News | 11.22.2011
By transforming microbes into miniature chemical factories, synthetic biology could lead to cheaper medicines, greener fuels and, to the distress...
By The Editors, Scientific American | 11.22.2011
In 2009 the San Francisco police arrested Lily Haskell when she allegedly attempted to come to the aid of a...
By Erika Check Hayden, Nature News | 11.22.2011
By transforming microbes into miniature chemical factories, synthetic biology could lead to cheaper medicines, greener fuels and, to the distress...
By The Editors, Scientific American | 11.22.2011
In 2009 the San Francisco police arrested Lily Haskell when she allegedly attempted to come to the aid of a...
By Eryn Brown, Los Angeles Times | 11.21.2011
For patients paralyzed by spinal cord injuries, Geron Corp.'s stem cell research was the shining hope.

The biotech firm showered...
By Sharon Kirkey, Postmedia News, Vancouver Sun | 11.21.2011
Women in Canada undergoing fertility treatments should be aware of a rare but potentially life-threatening complication, according to new guidelines...
By Tatia Megeneishvili, The Financial | 11.21.2011
For 26 year old Anna being a surrogate mother is her main source of income.

She is now pregnant with...
By Eryn Brown, Los Angeles Times | 11.21.2011
For patients paralyzed by spinal cord injuries, Geron Corp.'s stem cell research was the shining hope.

The biotech firm showered...